sedation in critically-ill covid-19 patients...prof. boris jung (montpellier, france) chairman prof....

1
Successful patient experience begins here Aspen Pharma Trading Limited 3016 Lake Drive, Citywest, Dublin 24, Ireland [email protected] www.aspenpharma.com www.aspencovid19.com E U R O P E C I S GL-PROP-11-20-00003 Why do we need sedation in critically-ill COVID-19 patients? Prof. Salvatore Maurizio MAGGIORE (Chieti, Italy) How should we manage sedation in critically-ill COVID-19 patients? Prof. Boris JUNG (Montpellier, France) Chairman Prof. Vito Marco RANIERI (Bologna, Italy) Sedation in critically-ill COVID-19 patients E-symposium on Monday 7 December 2020 12.30 – 13.30 CET 33 RD ANNUAL CONGRESS 6-9 DECEMBER ESICM Lives Digital

Upload: others

Post on 20-Feb-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Sedation in critically-ill COVID-19 patients...Prof. Boris JUNG (Montpellier, France) Chairman Prof. Vito Marco RANIERI (Bologna, Italy) Sedation in critically-ill COVID-19 patients

Successfulpatient experiencebegins here

Aspen Pharma Trading Limited3016 Lake Drive, Citywest, Dublin 24, Irelandaspenmedinfo@professionalinformation.co.ukwww.aspenpharma.comwww.aspencovid19.com

E U R O P E C I S

GL-

PR

OP

-11-

20-0

0003

Why do we need sedation in critically-ill COVID-19 patients?

Prof. Salvatore Maurizio MAGGIORE (Chieti, Italy)

How should we manage sedation in critically-ill COVID-19 patients?

Prof. Boris JUNG (Montpellier, France)

Chairman Prof. Vito Marco RANIERI (Bologna, Italy)

Sedation in critically-ill COVID-19 patientsE-symposium on Monday 7 December 2020

12.30 – 13.30 CET

33 RD ANNUALCONGRESS

6-9 DECEMBER

ESICM Lives Digital

ADVERT ESICM-210x276.indd 1ADVERT ESICM-210x276.indd 1 10/11/2020 16:0910/11/2020 16:09